BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1825 related articles for article (PubMed ID: 12617697)

  • 1. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
    Darmani NA
    Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
    Shah SA; Gupta AS; Kumar P
    J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids in clinical practice.
    Williamson EM; Evans FJ
    Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids and multiple sclerosis.
    Pertwee RG
    Pharmacol Ther; 2002 Aug; 95(2):165-74. PubMed ID: 12182963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacology of cannabinoid derivatives: are there applications to treatment of pain?].
    Beaulieu P; Rice AS
    Ann Fr Anesth Reanim; 2002 Jun; 21(6):493-508. PubMed ID: 12134594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of cannabinoids.
    Grotenhermen F
    Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids.
    Grotenhermen F
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Established and potential therapeutic applications of cannabinoids in oncology.
    Walsh D; Nelson KA; Mahmoud FA
    Support Care Cancer; 2003 Mar; 11(3):137-43. PubMed ID: 12618922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptors and their ligands.
    Pertwee RG; Ross RA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of cannabinoids in neurological diseases.
    Alsasua del Valle A
    Cell Mol Neurobiol; 2006; 26(4-6):579-91. PubMed ID: 16699878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptors and pain.
    Pertwee RG
    Prog Neurobiol; 2001 Apr; 63(5):569-611. PubMed ID: 11164622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection.
    Mechoulam R; Hanu L
    Pain Res Manag; 2001; 6(2):67-73. PubMed ID: 11854768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.
    Pertwee RG
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1553-71. PubMed ID: 11060760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.